Myomo (MYO) Gains from Sales and Divestitures (2017 - 2025)
Myomo posted quarterly Gains from Sales and Divestitures of $52821.0 for Q3 2025, up 23.33% year-on-year from $42828.0 in Q3 2024, and down 91.8% on a QoQ basis from $644149.0 in Q2 2025.
Myomo (MYO) has 9 years of Gains from Sales and Divestitures data on file, last reported at $52821.0 in Q3 2025.
- For the quarter ending Q3 2025, Gains from Sales and Divestitures rose 23.33% year-over-year to $52821.0; the trailing twelve-month figure through Sep 2025 stood at $52821.0 (up 23.33% YoY), and the FY2024 full-year result was $1.0 million, up 195.87% from the prior year.
- Gains from Sales and Divestitures for Q3 2025 stood at $52821.0, down from $644149.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $1.0 million in Q4 2024 and bottomed at $10.0 in Q1 2021.
- The 5-year median for Gains from Sales and Divestitures is $133270.0 (2022), against an average of $209609.4.
- The widest annual swing landed in 2021, when Gains from Sales and Divestitures plunged 99.85%; it then surged 971480.0% in 2022.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $153357.0 in 2021, then declined by 10.45% to $137332.0 in 2022, then soared by 147.14% to $339409.0 in 2023, then surged by 195.87% to $1.0 million in 2024, then tumbled by 94.74% to $52821.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $52821.0 (Q3 2025), $644149.0 (Q2 2025), and $59031.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 52,821.00 |
| Sep 30, 2025 | 52,821.00 |
| Jun 30, 2025 | 644,149.00 |
| Jun 30, 2025 | 644,149.00 |
| Mar 31, 2025 | 59,031.00 |
| Mar 31, 2025 | 59,031.00 |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 42,828.00 |
| Sep 30, 2024 | 42,828.00 |
| Jun 30, 2024 | 636,801.00 |
| Jun 30, 2024 | 636,801.00 |
| Mar 31, 2024 | 300,544.00 |
| Mar 31, 2024 | 300,544.00 |
| Dec 31, 2023 | 339,409.00 |
| Dec 31, 2023 | 339,409.00 |
| Sep 30, 2023 | 199,163.00 |
| Sep 30, 2023 | 199,163.00 |
| Jun 30, 2023 | 169,499.00 |
| Jun 30, 2023 | 169,499.00 |
| Mar 31, 2023 | 2,821.00 |
| Mar 31, 2023 | 2,821.00 |
| Dec 31, 2022 | 137,332.00 |
| Dec 31, 2022 | 137,332.00 |
| Sep 30, 2022 | 133,270.00 |
| Sep 30, 2022 | 133,270.00 |
| Jun 30, 2022 | 97,158.00 |
| Jun 30, 2022 | 97,158.00 |
| Mar 31, 2022 | 10,151.00 |
| Mar 31, 2022 | 10,151.00 |
| Dec 31, 2021 | 153,357.00 |
| Dec 31, 2021 | 153,357.00 |
| Sep 30, 2021 | 20.00 |
| Sep 30, 2021 | 20.00 |
| Jun 30, 2021 | 10.00 |
| Jun 30, 2021 | 10.00 |
| Mar 31, 2021 | 10.00 |
| Mar 31, 2021 | 10.00 |
| Dec 31, 2020 | 31,050.00 |
| Dec 31, 2020 | 31,050.00 |
| Sep 30, 2020 | 13,675.00 |
| Sep 30, 2020 | 13,675.00 |
| Jun 30, 2020 | 4,257.00 |
| Jun 30, 2020 | 4,257.00 |
| Mar 31, 2020 | 16.00 |
| Mar 31, 2020 | 16.00 |
| Dec 31, 2019 | 8,105.00 |
| Dec 31, 2019 | 8,105.00 |
| Sep 30, 2019 | 159,182.00 |
| Sep 30, 2019 | 159,182.00 |
| Jun 30, 2019 | 117,345.00 |
| Jun 30, 2019 | 117,345.00 |
| Mar 31, 2019 | 95,001.00 |
| Mar 31, 2019 | 95,001.00 |
| Dec 31, 2018 | 2,034.00 |
| Dec 31, 2018 | 2,034.00 |
| Sep 30, 2018 | 50,579.00 |
| Sep 30, 2018 | 50,579.00 |
| Jun 30, 2018 | 33,477.00 |
| Jun 30, 2018 | 33,477.00 |
| Mar 31, 2018 | 32,540.00 |
| Mar 31, 2018 | 32,540.00 |
| Dec 31, 2017 | 312.00 |
| Dec 31, 2017 | 312.00 |